CZMWY OTC
Carl Zeiss Meditec AG
1W: -1.0%
1M: -7.4%
3M: +7.3%
YTD: -24.2%
1Y: -31.5%
3Y: -58.5%
5Y: -83.9%
$35.14
+0.14 (+0.41%)
Weekly Expected Move ±3.8%
$32
$34
$35
$36
$38
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$4.1B
+19.8% ▲
5Y CAGR: +15.1%
Total Liabilities
$1.6B
+17.1% ▲
5Y CAGR: +22.7%
Shareholders Equity
$2.5B
+21.8% ▲
5Y CAGR: +11.7%
Cash & Investments
$27M
+34.4% ▲
5Y CAGR: +39.3%
Total Debt
$132M
-13.9% ▼
5Y CAGR: +14.1%
Net Debt
$105M
-21.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $7M | $8M | $11M | $20M | $27M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $7M | $8M | $11M | $20M | $27M |
| Net Receivables | $324M | $414M | $421M | $583M | $813M |
| Inventory | $286M | $383M | $520M | $536M | $497M |
| Other Current Assets | $977M | $1.9B | $959M | $68M | $165M |
| Total Current Assets | $1.6B | $1.8B | $1.9B | $1.2B | $1.5B |
| Property, Plant & Equip. | $200M | $236M | $251M | $354M | $343M |
| Goodwill & Intangibles | $482M | $670M | $429M | $1.7B | $1.9B |
| Long-Term Investments | $24M | $19M | $21M | $20M | $57M |
| Other Non-Current Assets | $785K | $34M | $420M | $31M | $160M |
| Total Non-Current Assets | $792M | $1.0B | $1.1B | $2.2B | $2.6B |
| Total Assets | $2.4B | $2.8B | $3.0B | $3.4B | $4.1B |
| — Liabilities — | |||||
| Accounts Payable | $145M | $189M | $240M | $184M | $128M |
| Short-Term Debt | $0 | -$40M | $0 | $2M | $44M |
| Deferred Revenue | $280M | $40M | $0 | $0 | $0 |
| Other Current Liabilities | $3M | $233M | $194M | $261M | $336M |
| Total Current Liabilities | $448M | $539M | $562M | $569M | $544M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $121M | $125M | $129M | $503M | $491M |
| Total Non-Current Liabilities | $270M | $253M | $298M | $768M | $732M |
| Total Liabilities | $719M | $793M | $860M | $1.3B | $1.6B |
| — Equity — | |||||
| Common Stock | $89M | $89M | $89M | $89M | $105M |
| Retained Earnings | $1.0B | $1.2B | $1.4B | $1.5B | $1.9B |
| Accumulated OCI | -$51M | $92M | $44M | -$4M | -$21M |
| Total Stockholders Equity | $1.7B | $2.0B | $2.2B | $2.0B | $2.5B |
| Total Liabilities & Equity | $2.4B | $2.8B | $3.0B | $3.4B | $4.1B |
| — Key Metrics — | |||||
| Total Debt | $121M | $128M | $156M | $154M | $132M |
| Net Debt | $114M | $120M | $145M | $134M | $105M |
| Total Investments | $24M | $19M | $21M | $20M | $57M |